Navigation Links
Ebola-outbreak kills 5000 gorillas

The study also provides new hope for controlling the devastating impact of Ebola on wild gorilla and chimpanzee populations. Since reports of ape die-offs first circulated widely in 2003, sceptics have doubted how large these die-offs were and whether Ebola was even the cause. The new study, led by Magdalena Bermejo of the University of Barcelona, allays these doubts because it was conducted in a closely monitored gorilla population where genetic tests confirmed Ebola as the cause of death. Bermejo and colleagues from the Max Planck Institute for Evolutionary Anthropology and Uppsala University first showed that 93% (221 of 238) individually known gorillas at the Lossi Sanctuary in northwest Congo were killed by Ebola during outbreaks in 2002 and 2003. They then used transect surveys to show that 95% gorilla mortality rates extended over a much larger area of several thousand square kilometres. Chimpanzees were also heavily affected, with a mortality rate of 77%.

Lossi was just one in a series of large gorilla and chimpanzee die-offs caused by Ebola over the last twelve years. Accurate figures on exactly how many apes have died are not yet available. But given the large amount of prime habitat affected, these Ebola outbreaks may have killed as much as 25% of the world gorilla population. Particularly troubling has been the concentration of Ebola impact on large, remote protected areas that were designed to be the bulwarks of ape conservation efforts. Ebola has not totally made apes totally extinct from these areas but it has pushed once huge populations down to smaller sizes at which they are dramatically less resilient to illegal hunting and other looming threats.

Just as troubling are recent studies showing that the Ebola infection wave is spreading rapidly towards several of the remaining large protected areas in the region. Results from the new study suggest that protecting these remaining ape populations from Ebola may be much more feasible tha n previously appreciated. At Lossi, most gorillas appeared not to be infected directly from some reservoir host, as previously assumed. Rather, initial spillover from a reservoir host appeared to trigger an epidemic that spread from gorilla social group to gorilla social group. This opens the door to targeted vaccination strategies that, by breaking the chain of transmission, could be much more efficient than in the case of outbreaks driven entirely by reservoir spillover. The consistent spread rate of the Ebola infection wave also suggests that vaccination could be targeted just ahead of the advancing wave.

The current lack of a vaccination program is not due to a lack of vaccine options, as several different vaccines have now protected laboratory monkeys from Ebola and major vaccine labs are anxious to help. Rather, "Uncertainty about whether a large Ebola control effort was necessary or even possible has paralyzed large donors and major conservation organizations," said Peter Walsh, a co-author from Max Planck. "We are hoping that the starkness of our results will push some public or private donor to finally commit the two or three million dollars necessary to develop a safe and effective way of delivering Ebola vaccine to wild apes."

Walsh contends that Ebola vaccination is a cost effective method of ape conservation. "People in the conservation community are intimidated by the up-front costs of vaccination and would prefer to instead spend the money on anti-poaching. What they are not factoring in is the fact that one year of Ebola vaccination could save as many apes as decades of anti-poaching. We need to do both."

Walsh also points out that Ebola has the potential to quickly destroy years of ecotourism investment. For example, Bermejo’s gorilla habituation program at Lossi was set up in the mid-1990’s in collaboration with the European Union’s Ecosystem Forestiere d’Afrique Centrale (ECOFAC) project to bring ecotourism revenue to local people. Ebola not only wiped out the habituated gorillas at Lossi, it also neutralized years of ecotourism investment in neighbouring Odzala National Park by devastating gorilla populations there.

"We are in a period where relatively modest investments in both Ebola control and anti-poaching would go a very long way towards insuring the future of our closest relatives," said Walsh. "Let’s not blow it."
'"/>

Source:Max-Planck-Gesellschaft


Related biology news :

1. Study: Harmless virus kills some cancers
2. VCU study shows hormone-like molecule kills cells that cause inflammation in allergic disease
3. Scientists develop nanotech-laser treatment that kills cancer cells without harming healthy tissue
4. Restoring silenced suppressor gene kills lung-cancer cells
5. Cell therapy slows progression of an inherited neurological disease; Improves motor skills in mice
6. Newly discovered protein kills anthrax bacteria by exploding their cell walls
7. New vaccine for condition that kills 500,000 children a year
8. Experimental RNA-based drug kills prostate cancer cells effectively and safely
9. HIV-1 kills immune cells in the gut that may never bounce back
10. Surgeons with video game skill appear to perform better in simulated surgery skills course
11. Antifungal drug kills TB bug

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... SARASOTA, FL (PRWEB) , ... ... ... Inc. (RPS®) today announces publication of a United States multicenter, prospective clinical ... single use, disposable, point-of-care diagnostic test capable of identifying clinically significant acute ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology: